Pfizer Developing New Methods For Detecting Hepatotoxicity Signals
This article was originally published in The Pink Sheet Daily
Executive Summary
Current methods for detecting hepatotoxicity have no mathematical basis, Pfizer says. The company plans to evaluate patient data for Rezulin and Trovan, which were the subject of liver toxicity concerns.